SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

MEME COIN: $ROAR is the OG token. Est. Sept '22. Inspired by The Roaring Kitty Who Inspired other to fight against wall street through Game Stop.  We Are  100% community-owned.  LP burnt.  Contract Renounced  Ready to Moon like $GME &amp; $AMC?

Roaring Kitty

The Roaring Kitty token ($ROAR) is currently trending as a community-driven play that aims to capture the momentum of the GameStop (GME) narrative and retail investor sentiment. Community members are actively highlighting the project's decentralized structure, ongoing liquidity pool developments, and potential exchange listings as key catalysts for growth.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending as investors weigh its 50th anniversary milestone against heightened geopolitical risks, specifically threats from Iranian officials targeting major U.S. tech firms. Additionally, the community is heavily engaged in speculative discussions regarding a high-stakes patent infringement dispute with Xiao-I Corporation, with many debating the potential for a substantial settlement or buyout to resolve the long-standing legal battle.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as investors and social media users fiercely debate the company's prospects amid high-stakes geopolitical tensions involving Iran, escalating military rhetoric, and concerns over the company's financial stability. Community members are actively clashing over the potential for market volatility, the impact of recent diplomatic developments, and the broader influence of political news on the stock's performance.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently facing intense selling pressure and high-urgency institutional options activity following a significant downgrade by JPMorgan, which warned of a potential 60% downside. The community is sharply divided, with bearish traders highlighting technical weakness and the risk of capital rotation into the upcoming SpaceX IPO, while long-term bulls characterize the recent dip as a tactical manipulation by banks to accumulate shares at lower valuations.

XYO is the original and one of the largest Decentralized Physical Infrastructure Networks (DePIN), boasting over 10 million nodes and consistently leading DePIN in both scale and revenue generation. Launching its Mainnet ahead of any other DePIN, XYO specializes in collecting and validating real-world data, bridging it seamlessly to Web3 and Web2 companies across AI, geolocation, and other critical data sectors. At the core of XYO are Proof of Location and Proof of Origin technologies, enabling accurate validation of real-world data for innovative use cases such as Real-World Asset (RWA) tracking, DePIN applications, real-world gaming, and treasure hunts. Recently, XYO expanded its ecosystem by launching the XYO Layer One blockchain, purpose-built to support the intensive data demands of DePIN, RWA, AI, and similar data-driven industries. XYO employs a unique dual-token model: XYO Token: An externally traded token supporting the DePIN ecosystem, rewards, staking, and governance, enhancing overall ecosystem value and scarcity.   XL1 Token: Internal to the XYO Layer One blockchain, facilitating transactions, gas fees, and other blockchain-specific use cases. The dual-token economics are strategically designed to increase scarcity and promote sustainable growth. The XYO token is available on major exchanges, including Coinbase. The XL1 token will launch publicly later in 2025. To accelerate network adoption and growth, XYO created the popular COIN app. Beyond the XYO Foundation, the team founded the U.S.-based, for-profit entity XY Labs Inc., notable as the first U.S. crypto company qualified by the SEC for a Regulation A offering, permitting share sales to both accredited and non-accredited investors. XY Labs further stands out as one of the pioneering U.S. companies to tokenize and publicly list its shares. These tokenized shares trade as $XYLB on the tZERO ATS, positioning XY Labs prominently in the growing wave of Real-World Asset (RWA) tokenization.

XYO Network

XYO Network remains a polarizing asset, with a vocal community debating whether its position in the DePin sector justifies long-term holding despite frequent, sharp price retracements. While many investors are frustrated by stagnant price action and past unfulfilled promotional hype, others continue to accumulate, betting that future adoption and blockchain utility will eventually trigger a significant breakout.

SPDR S&P 500 ETF TRUST - Units of undivided interest in SPDR Trust Series 1

SPY is experiencing high volatility as investors closely monitor a looming deadline for potential military escalation in Iran, with market sentiment wavering between fears of a wider energy crisis and hopes for a negotiated breakthrough. The community is actively debating the credibility of these ultimatums, often referring to them as 'Taco Tuesday' maneuvers, while analyzing how ongoing tensions and geopolitical uncertainty will impact broader market stability.

Kratos Defense & Security Solutions, Inc. engages in the provision of mission critical products, services and solutions for United States national security priorities. It operates through the Kratos Government Solutions (KGS) and Unmanned Systems (US) segments. The KGS segment consists of an aggregation of KGS operating segments, including microwave electronic products, space, satellite and cyber, training solutions. The US segment refers to the unmanned aerial, unmanned ground, unmanned seaborne and related command, control and communications system businesses. The company was founded on December 19, 1994, and is headquartered in Round Rock, TX.

Kratos Defense & Security Solutions Inc

Kratos Defense & Security Solutions is trending following the announcement of a $1.2 billion public stock offering, a move the company says will fund the rapid scaling of its drone and hypersonic missile production to meet surging defense demand. While the stock has faced downward volatility as investors digest the dilution, community members are actively debating whether this is a short-term hurdle or a strategic 'war chest' setup for long-term growth, with many long-term holders viewing the pullback as a buying opportunity given the massive backlog and escalating geopolitical tensions.

Invesco Exchange-Traded Fund Trust II - Invesco KBW Bank ETF

Invesco KBW Bank ETF

The Invesco KBW Bank ETF is currently capturing investor interest amid ongoing volatility in the banking sector and diverging perspectives on interest rate policy. Market participants are closely watching the ETF for signals of stability as the sector grapples with shifting credit concerns and broader economic uncertainty.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is generating intense debate as investors weigh a potential short squeeze against concerns regarding long-term profitability and upcoming lockup expirations. While the community is split between bullish sentiment driven by recent insider buying and the massive $8.3 billion antitrust lawsuit against Google, others remain skeptical about the firm's path to sustainability in a challenging credit environment.

$RARI is an ERC-20 token that controls the RARI Foundation treasury and governs the Rarible protocol and RARI Chain. The token was issued in 2020 with a max. supply of 25 million $RARI.

Rarible

Rarible is generating significant buzz due to its ultra-low circulating supply of 19 million coins and a market cap that supporters view as severely undervalued. The community is actively discussing the potential for a massive price surge driven by scarcity and upcoming integrations in the DePin and DeFi sectors, with many investors advocating for a buy-and-hold strategy to trigger a supply shock.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wall Street Analysts Think ArriVent BioPharma, Inc. (AVBP) Could Surge 72.44%: Read This Before Placing a Bet

The mean of analysts' price targets for ArriVent BioPharma, Inc. (AVBP) points to a 72.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

ArriVent BioPharma (NASDAQ:AVBP) Trading Up 8.4%  - Here's Why

ArriVent BioPharma (NASDAQ:AVBP) Trading 8.4% Higher - Still a Buy...

ArriVent BioPharma, Inc. (NASDAQ:AVBP) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the twelve analysts that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has assigned...

Are Medical Stocks Lagging  ArriVent BioPharma, Inc. (AVBP) This Year?

Here is how ArriVent BioPharma, Inc. (AVBP) and Brainsway Ltd. Sponsored ADR (BWAY) have performed compared to their sector so far this year.

ArriVent BioPharma (NASDAQ:AVBP) Upgraded to Strong-Buy at Truist Financial

Truist Financial raised shares of ArriVent BioPharma to a "strong-buy" rating in a research note on Wednesday...

ArriVent BioPharma (NASDAQ:AVBP) Price Target Raised to $45.00 at B. Riley Financial

B. Riley Financial upped their price target on ArriVent BioPharma from $37.00 to $45.00 and gave the company a "buy" rating in a report on Monday...

ArriVent BioPharma (AVBP) Expected to Announce Quarterly Earnings on Thursday

ArriVent BioPharma (NASDAQ:AVBP) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 26. (View Earnings Report at...

ArriVent BioPharma, Inc. $AVBP Shares Sold by Hidden Lake Asset Management LP

Hidden Lake Asset Management LP cut its stake in ArriVent BioPharma, Inc. (NASDAQ:AVBP - Free Report) by 48.3% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The...

ArriVent BioPharma's (AVBP) Buy Rating Reaffirmed at BTIG Research

BTIG Research reissued a "buy" rating and set a $42.00 target price on shares of ArriVent BioPharma in a research report on Thursday...

ArriVent BioPharma (NASDAQ:AVBP) Sees Strong Trading Volume - Here's What Happened

ArriVent BioPharma (NASDAQ:AVBP) Sees Strong Trading Volume - Here's Why...

Arrivent Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in identifying, licensing, and globalizing biopharma innovations from around the world to deliver important medicines to patients. The company was founded Zheng Bin Yao and Stuart Lutzker on April 14, 2021 and is headquartered in Newtown Square, PA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.89	--	--	N/A
Q4 '25	-$0.85	-$0.84	0.78%	BEAT
Q3 '25	-$0.79	-$0.83	-5.15%	MISSED
Q2 '25	-$0.71	-$0.90	-26.37%	MISSED
Q1 '25	-$0.66	-$1.90	-186.14%	MISSED

AVBP
ArriVent BioPharma Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest AVBP News

AVBPArriVent BioPharma Inc.